603122-40-3

Basic information

• Product Name: 3-METHOXY-4-METHOXYCARBONYLPHENYLBORONIC ACID, PINACOL ESTER
• Synonyms: 3-METHOXY-4-METHOXYCARBONYLPHENYLBORONIC ACID, PINACOL ESTER;REF DUPL: 2,6-Dihydroxybenzonitrile;REF DUPL: 3-Methoxy-4-(methoxycarbonyl)phenylboronic acid pinacol ester;Methyl 2-Methoxy-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzoate;Methyl 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)
• CAS NO: 603122-40-3
• Molecular Formula: C₁₅H₂₁BO₅
• Molecular Weight: 292.14
• Mol File: 603122-40-3.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 400.806°C at 760 mmHg
• Flash Point: 196.201°C
• Appearance: /
• Density: 1.113g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.498
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-METHOXY-4-METHOXYCARBONYLPHENYLBORONIC ACID, PINACOL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 3-METHOXY-4-METHOXYCARBONYLPHENYLBORONIC ACID, PINACOL ESTER(603122-40-3)
• EPA Substance Registry System: 3-METHOXY-4-METHOXYCARBONYLPHENYLBORONIC ACID, PINACOL ESTER(603122-40-3)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-37/39
• WGK Germany: 3
• Hazardous Substances Data: 603122-40-3(Hazardous Substances Data)

Usage

General Description

3-Methoxy-4-methoxycarbonylphenylboronic Acid, Pinacol Ester is a complex organic chemical compound that falls under the category of boronic acids. It is used mainly in chemical synthesis. Known for its key role in Suzuki coupling, it is involved in various chemical reactions including catalytic cycles. 3-METHOXY-4-METHOXYCARBONYLPHENYLBORONIC ACID, PINACOL ESTER is also valuable in pharmaceutical research, often used in the creation of drugs due to its ability to facilitate carbon-carbon bond formation. With its ester form, it offers enhanced stability and helps prevent unwanted side reactions. Like most chemicals in its category, it must be handled carefully due to its reactive properties.

InChI:InChI=1/C15H21BO5/c1-14(2)15(3,4)21-16(20-14)10-7-8-11(13(17)19-6)12(9-10)18-5/h7-9H,1-6H3

Upstream product

• 139102-34-4 methyl 4-bromo-2-methoxybenzoate 
• 73183-34-3 bis(pinacol)diborane 
• 1666-28-0 4-bromosalicylic acid 
• 22717-56-2 4-bromo-2-Hydroxybenzoic Acid Methylester 
• 72135-36-5 4-bromo-2-methoxybenzoic acid 

Downstream Products

• 1009303-64-3 4-[2,4-bis-((S)-3-methyl-morpholin-4-yl)-pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-benzoic acid methyl ester 
• 603122-41-4 (3-methoxy-4-(methoxycarbonyl)phenyl)boronic acid 
• 1056636-09-9 methyl 4-(2-chloro-5-methylpyrimidin-4-yl)-2-methoxybenzoate 
• 1246381-15-6 4-{4-chloro-3-[2-(2-chloro-pyridin-4-yl)-3,3,3-trifluoro-2-hydroxy-1-methyl-propyl]-phenoxy}-2-methoxy-benzoic acid methyl ester 
• 1246380-71-1 4-{3-chloro-4-[2-(2-chloro-pyridin-4-yl)-3,3,3-trifluoro-2-hydroxy-1-methyl-propyl]-phenoxy}-2-methoxy-benzoic acid 
• 1254328-50-1 methyl 4-(3-amino-6-(3,4,5-trimethoxyphenyl)pyrazin-2-yl)-2-methoxybenzoate 
• 1364267-50-4 methyl 4-(2-amino-5-bromopyridin-3-yl)-2-methoxybenzoate 
• 1364267-61-7 C₁₄H₁₅BN₂O₅ 
• 1364267-87-7 methyl 4-(2-amino-5-(thiophen-2-yl)pyridin-3-yl)-2-methoxybenzoate 
• 1364267-95-7 methyl 4-(2-amino-5-(4-((dimethylamino)methyl)thiophen-2-yl)pyridin-3-yl)-2-methoxybenzoate 
• 1364268-90-5 4-(2-amino-5-(thiophen-2-yl)pyridin-3-yl)-2-methoxybenzamide 
• 1621254-90-7 methyl 5'-(2-(((4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-4-methyl-2-oxooxazolidin-3-yl)methyl)-4,4-dimethylcyclohex-1-enyl)-2'-fluoro-3,4'-dimethoxybiphenyl-4-carboxylate 
• 1621254-37-2 methyl 3'-(2-(((4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-4-methyl-2-oxooxazolidin-3-yl)methyl)-4,4-dimethylcyclohex-1-enyl)-3,4'-dimethoxybiphenyl-4-carboxylate 

Relevant articles and documents

TYK2 Inhibitor compounds containing alkoxy and amide groups

The invention belongs to the field of pharmaceutical chemistry, and provides TYK2 inhibitor compounds containing alkoxy and amide groups and a preparation method thereof, and relates to application of the compound in preparation of medicines for treating

CANCER TREATMENTS TARGETING CANCER STEM CELLS

Disclosed are compounds, methods, compositions, and kits that allow for treating cancer by, e.g., targeting cancer stem cells. In some embodiments, the cancer is colorectal cancer, gastric cancer, gastrointestinal stromal tumor, ovarian cancer, lung cancer, breast cancer, pancreatic cancer, prostate cancer, testicular cancer, or lymphoma. In some embodiments, the cancer is liver cancer, endometrial cancer, leukemia, or multiple myeloma. The compounds utilized in the disclosure are of Formula (0), (O'), and (I):

TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

The present invention is directed to tricyclic compounds (I), pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.